Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 7/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.40 |
| ▸ | GNAO1 | P09471 | 7/20 | 0.39 |
| ▸ | GNAI3 | P08754 | 6/20 | 0.39 |
| ▸ | GNAI1 | P63096 | 6/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
| ▸ | CCR2 | P41597 | 1/20 | 0.33 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30859683 | 0.97 | SIGMAR1 (0.41) | CXCR4SIGMAR1GNAO1GNAI3GNAI1 | |
| SCHEMBL18699333 | 0.97 | SIGMAR1 (0.41) | CXCR4SIGMAR1GNAO1GNAI3GNAI1 | |
| SCHEMBL26331040 | 0.97 | SIGMAR1 (0.41) | CXCR4SIGMAR1GNAO1GNAI3GNAI1 | |
| SCHEMBL19442064 | 0.93 | SIGMAR1 (0.40) | CXCR4SIGMAR1GNAO1GNAI3GNAI1 | |
| SCHEMBL18761564 | 0.90 | GNAO1 (0.46) | SIGMAR1GNAO1GNAI3GNAI1SLC6A2 | |
| SCHEMBL22019451 | 0.90 | GNAO1 (0.46) | SIGMAR1GNAO1GNAI3GNAI1SLC6A2 | |
| SCHEMBL21581280 | 0.90 | GNAO1 (0.46) | SIGMAR1GNAO1GNAI3GNAI1SLC6A2 | |
| SCHEMBL22702328 | 0.90 | GNAO1 (0.42) | SIGMAR1GNAO1GNAI3GNAI1SLC6A2 | |
| SCHEMBL21581261 | 0.90 | GNAO1 (0.46) | SIGMAR1GNAO1GNAI3GNAI1SLC6A2 | |
| SCHEMBL18612783 | 0.90 | GNAO1 (0.46) | SIGMAR1GNAO1GNAI3GNAI1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1370563-B1 | MESOPOROUS ORGANIC-INORGANIC HYBRID MATERIALS FOR SEPARATING GASES | CENTRE NAT RECH SCIENT (FR) | 2006-09-06 | — | — | EP | claimed |
| US-20040122250-A1 | Mesoporous organic-inorganic hybrid materials for separating gases | CENTRE NATIONAL DE LA RECHERCHE-SCIENTIFIQUE (FR) | 2004-06-24 | — | — | US | claimed |
| US-7517512-B2 | Mesoporous organic-inorganic hybrid materials for separating gases | CENTRE NATIONAL DE LA RECHERCHE-SCIENTIFIQUE (FR) | 2009-04-14 | — | — | US | disclosed |
| US-7452845-B2 | Mesoporous organic-inorganic hybrid materials for separating gases | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2008-11-18 | — | — | US | disclosed |
| US-20080152561-A1 | MESOPOROUS ORGANIC-INORGANIC HYBRID MATERIALS FOR SEPARATING GASES | CENTRE NATIONAL DE LA RECHERCHE-SCIENTIFIQUE (FR) | 2008-06-26 | — | — | US | disclosed |
| EP-1370563-B1 | MESOPOROUS ORGANIC-INORGANIC HYBRID MATERIALS FOR SEPARATING GASES | CENTRE NAT RECH SCIENT (FR) | 2006-09-06 | — | — | EP | disclosed |
| EP-1325939-B1 | Process for preparing co-gels having polyazacycloalkane moieties and their use | AIR LIQUIDE (FR) | 2006-06-14 | — | — | EP | disclosed |
| US-20040122250-A1 | Mesoporous organic-inorganic hybrid materials for separating gases | CENTRE NATIONAL DE LA RECHERCHE-SCIENTIFIQUE (FR) | 2004-06-24 | — | — | US | disclosed |
| EP-1325939-A2 | Process for preparing co-gels having polyazacycloalkane moieties and their use | L'Air Liquide S. A. à Directoire et Conseil de Surveillance pour l'Etude et l'Exploitation des Procédés Georges Claude (FR) | 2003-07-09 | — | — | EP | disclosed |
| EP-1051422-B1 | SILICA GEL INCORPORATING POLYAZACYCLOALKANE STRUCTURAL UNITS | AIR LIQUIDE (FR) | 2003-07-02 | — | — | EP | disclosed |
| EP-1051257-B1 | METHOD FOR PREPARING POLYAZACYCLOALKANES GRAFTED ON SILICA GEL AND USE OF GRAFTED COMPOUNDS | AIR LIQUIDE (FR) | 2002-04-03 | — | — | EP | disclosed |
| EP-1051257-A1 | METHOD FOR PREPARING POLYAZACYCLOALKANES GRAFTED ON SILICA GEL AND USE OF GRAFTED COMPOUNDS | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2000-11-15 | — | — | EP | disclosed |
| EP-1051422-A1 | SILICA GEL INCORPORATING POLYAZACYCLOALKANE STRUCTURAL UNITS | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 2000-11-15 | — | — | EP | disclosed |
| WO-1999037399-A1 | METHOD FOR PREPARING POLYAZACYCLOALKANES GRAFTED ON SILICA GEL AND USE OF GRAFTED COMPOUNDS | L'AIR LIQUIDE SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 1999-07-29 | — | — | WO | disclosed |
| WO-1999037656-A1 | SILICA GEL INCORPORATING POLYAZACYCLOALKANE STRUCTURAL UNITS | L'AIR LIQUIDE SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 1999-07-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040122250-A1 | Mesoporous organic-inorganic hybrid materials for separating gases | SCO2, IPO9, IPO4 | CXCR4 1677/4885SIGMAR1 17/4885GNAO1 320/4885 |
| US-20080152561-A1 | MESOPOROUS ORGANIC-INORGANIC HYBRID MATERIALS FOR SEPARATING GASES | ZYX, IPO9, IPO4 | CXCR4 1130/4885SIGMAR1 75/4885GNAO1 545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.